Cargando…
Shift in skin microbiota of children with atopic dermatitis after topical gentian violet application
INTRODUCTION: Increasing usage of antimicrobial agents may contribute to bacterial resistance in atopic dermatitis (AD). In this case an alternative topical treatment might be gentian violet (GV), suggested for its antibacterial and antifungal properties. AIM: To assess the microbial composition of...
Autores principales: | Krzysiek, Joanna, Żurawska-Olszewska, Joanna, Szczerba, Izabela, Lesiak, Aleksandra, Pastuszak-Lewandoska, Dorota, Grzegorczyk, Janina, Ciążyńska, Magdalena, Narbutt, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258698/ https://www.ncbi.nlm.nih.gov/pubmed/37312917 http://dx.doi.org/10.5114/ada.2023.126534 |
Ejemplares similares
-
The role of heterodimer IL-17-A/F in atopic dermatitis
por: Krzysiek, Joanna, et al.
Publicado: (2022) -
Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
por: Sieniawska, Joanna, et al.
Publicado: (2022) -
COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
por: Ceryn, Justyna, et al.
Publicado: (2021) -
Treatment of recalcitrant mycosis fungoides with topical gentian violet
por: Cowan, Natasha, et al.
Publicado: (2019) -
Off-label medications in the treatment of hospitalized children with atopic dermatitis
por: Niedźwiedź, Michał, et al.
Publicado: (2022)